RUSSELL SPRINGS, KY – PremierTox Laboratory is pleased to announce it has been awarded accreditation from the College of American Pathologists (CAP) following an extensive on-site review as part of the CAP’s Accreditation Programs. PremierTox is now a member of an elite group of more than 7,700 CAP-accredited facilities worldwide.
The laboratory medical director for PremierTox, Richard Lozano, M.D., was advised of this national recognition, and congratulated for the excellence of the services being provided to physicians and their patients every day.
Revitalized under new ownership and management, PremierTox is an emerging leader in the field of toxicology lab services, helping healthcare professionals personalize medication therapy and treatment monitoring to improve long-term outcomes for patients, providers, and insurance companies alike. “This is a national endorsement of the impeccable quality of our services, our integrity, and our highest standard of care for patients,” said, PremierTox President, Steve Klipp. “At PremierTox, it’s always more than a test result to us, and CAP accreditation reflects the intense attention our dedicated team of scientists and clinical experts give every test, every detail, to keep our promises to physicians and their patients across the country.”
"PremierTox is an emerging leader in the field of toxicology lab services..."
CAP accreditation, considered one of the most comprehensive and scientifically-endorsed benchmarks of excellence for laboratories in the U.S., is confirmation of PremierTox Laboratory’s steadfast dedication to providing high quality, transparent services centered on the knowledge that there is always a person behind every test. During the CAP accreditation process - designed to ensure the highest standard of care for all laboratory patients - inspectors examined PremierTox records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, instrumentation and equipment, facilities, safety program and record, and laboratory management.
PremierTox Laboratory’s state-of-the-art facility utilizes cutting-edge science and technology to provide rapid, accurate drug detection to clinicians on the front lines against medication abuse and diversion. Through advanced research and development, PremierTox offers proprietary testing methods that support individualized medication therapy and monitoring, at a reduced cost to the patient. With this new endorsement from CAP, PremierTox is excited to now further extend their exclusive services to: regional and national payers; federally sponsored entities such as the VA, GSA, and NIH; and directly to hospitals and their affiliated network of providers.
This is an important designation from CAP that recognizes and affirms the industry-leading services at PremierTox Laboratory, and the highest standard of care it provides for patients.
© 2017 PremierTox Laboratory